“The law of patents is not always patently clear, but one point is obvious. The question of obviousness is not one that admits of endless elaboration. It is, in fact, obvious.
In a judgment handed down yesterday, MedImmune Ltd v Novartis Pharmaceuticals UK Ltd  EWCA Civ 1234, the Court of Appeal, dismissing appeals from Arnold J  EWHC 1669 (Pat) and  EWHC 181 (Pat) made a number of observations on the matter.”
ICLR Blog, 11th October 2012